• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非感染艾滋病毒女性的肛门人乳头瘤病毒(HPV)患病率及赛沛Xpert和杂交捕获2(hc2)HPV检测方法的性能

Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women.

作者信息

Mbulawa Zizipho Z A, Wilkin Timothy, Goeieman Bridgette J, Jong Eefje, Michelow Pamela, Swarts Avril, Smith Jennifer S, Kegorilwe Patricia, Firnhaber Cynthia S, Williamson Anna-Lise

机构信息

Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Center for HIV and STIs, National Institute for Communicable Disease, National Health Laboratory Service, Cape Town, South Africa.

出版信息

Am J Clin Pathol. 2017 Aug 1;148(2):148-153. doi: 10.1093/ajcp/aqx050.

DOI:10.1093/ajcp/aqx050
PMID:28898982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5848307/
Abstract

OBJECTIVES

This study investigated anal high-risk HPV (HR-HPV) prevalence in HIV-infected women using the Cepheid Xpert HPV assay and compares its performance with that of Hybrid Capture-2 (hc2).

METHODS

A total of 199 HIV-infected women were recruited from Helen Joseph Hospital, Johannesburg. Stored ThinPrep anal swabs that had previously been tested using hc2 were tested for HPV using Xpert.

RESULTS

The HR-HPV prevalence by Xpert was 40.8% and similar to hc2 (41.8%) with overall agreement of 86.7%; Cohen's kappa 0.73 (95% CI 0.63-0.82). High grade squamous intraepithelial lesions (HSIL) was associated with increasing number of multiple HPV infection (P < .001). Xpert and hc2 were similarly sensitive (77.4% and 77.4%, respectively) and specific (66.1% and 64.8% respectively) for HSIL detection. HPV16 (OR: 14.0, 95% CI: 3.9-48.0, P < .0001), HPV39/68/56/66 (OR: 4.1, 95% CI: 1.4-12, P = .01) and HPV51/59 (OR: 2.8, 95% CI: 1.1-7.6, P = .04) were independently associated with anal HSIL.

CONCLUSIONS

Xpert HPV typing is a promising anal screening test in HIV-infected women that performs similarly to hc2.

摘要

目的

本研究使用赛沛Xpert HPV检测法调查了HIV感染女性的肛门高危型人乳头瘤病毒(HR-HPV)感染率,并将其检测性能与杂交捕获-2(hc2)检测法进行比较。

方法

从约翰内斯堡的海伦·约瑟夫医院招募了199名HIV感染女性。使用赛沛Xpert检测法对之前已用hc2检测过的保存的液基薄层制片肛门拭子进行HPV检测。

结果

赛沛Xpert检测法的HR-HPV感染率为40.8%,与hc2检测法(41.8%)相似,总体一致性为86.7%;科恩kappa系数为0.73(95%可信区间0.63 - 0.82)。高级别鳞状上皮内病变(HSIL)与多种HPV感染数量增加相关(P < 0.001)。赛沛Xpert检测法和hc2检测法在检测HSIL方面的敏感性(分别为77.4%和77.4%)和特异性(分别为66.1%和64.8%)相似。HPV16(比值比:14.0,95%可信区间:3.9 - 48.0,P < 0.0001)、HPV39/68/56/66(比值比:4.1,95%可信区间:1.4 - 12,P = 0.01)和HPV51/59(比值比:2.8,95%可信区间:1.1 - 7.6,P = 0.04)与肛门HSIL独立相关。

结论

赛沛Xpert HPV分型检测法在HIV感染女性中是一种很有前景的肛门筛查检测方法,其性能与hc2检测法相似。

相似文献

1
Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women.南非感染艾滋病毒女性的肛门人乳头瘤病毒(HPV)患病率及赛沛Xpert和杂交捕获2(hc2)HPV检测方法的性能
Am J Clin Pathol. 2017 Aug 1;148(2):148-153. doi: 10.1093/ajcp/aqx050.
2
Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.Xpert人乳头瘤病毒检测对于HIV血清反应阳性女性而言是一种很有前景的宫颈癌筛查检测方法。
Papillomavirus Res. 2016 Dec;2:56-60. doi: 10.1016/j.pvr.2016.02.004. Epub 2016 Mar 3.
3
Interest of cytology combined with Xpert HPV and Anyplex II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.细胞学检查联合 Xpert HPV 和 Anyplex II HPV28 检测人乳头瘤病毒 (HPV) 分型在抗逆转录病毒治疗的 HIV 感染患者中的应用:肛门和宫颈 HPV 病变的差异特征。
HIV Med. 2018 Nov;19(10):698-707. doi: 10.1111/hiv.12661. Epub 2018 Jul 30.
4
Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.比较 digene HC2 HPV DNA 检测法和 INNO-LiPA HPV 基因分型检测法在检测 HIV 阳性非洲女性高危型 HPV 感染和宫颈癌前病变中的分析性能和临床性能。
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):162-8. doi: 10.1097/QAI.0000000000000428.
5
Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.五种检测人乳头瘤病毒生殖器感染的检测方法的分析性能与临床性能比较。
J Virol Methods. 2017 Oct;248:238-243. doi: 10.1016/j.jviromet.2017.07.009. Epub 2017 Jul 21.
6
Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.布基纳法索和南非艾滋病毒 1 型感染者中宫颈癌筛查和筛查分流策略的诊断准确性:一项队列研究。
PLoS Med. 2021 Mar 4;18(3):e1003528. doi: 10.1371/journal.pmed.1003528. eCollection 2021 Mar.
7
Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.评估基于多重实时 PCR 检测的自我采集宫颈阴道灌洗液样本中人乳头瘤病毒感染的方法。
J Virol Methods. 2013 Oct;193(1):131-4. doi: 10.1016/j.jviromet.2013.05.009. Epub 2013 May 23.
8
Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.人乳头瘤病毒 mRNA 检测在 HIV 感染的男男性行为人群中用于检测肛门高级别鳞状上皮内病变。
J Med Virol. 2015 Aug;87(8):1397-403. doi: 10.1002/jmv.24188. Epub 2015 May 1.
9
Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.在具有意义不明确的非典型鳞状细胞的HPV感染女性中,由阴道镜检查和HR-HPV状态引导的穿刺活检对于识别即刻高级别鳞状上皮内病变或更严重病变更有效。
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:32-36. doi: 10.1016/j.ejogrb.2016.10.005. Epub 2016 Oct 23.
10
High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.在泰国北部,对宫颈细胞学轻度异常的女性进行 HPV16/18/52/58 型联合 HPV 检测和基因分型具有较高的性能。
J Med Virol. 2016 Jan;88(1):135-43. doi: 10.1002/jmv.24290. Epub 2015 Jun 30.

引用本文的文献

1
Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals.绘制南非女性人乳头瘤病毒图谱:病毒基因型、微生物群和免疫信号的系统评价与荟萃分析
Viruses. 2024 Dec 8;16(12):1893. doi: 10.3390/v16121893.
2
Challenges with the use of Xpert HPV as a screening tool for oral HPV among people living with HIV (PLHIV): experiences from Pune, India.Xpert HPV 作为 HIV 感染者(PLHIV)口腔 HPV 筛查工具的应用挑战:来自印度浦那的经验。
BMC Infect Dis. 2023 Apr 17;23(1):233. doi: 10.1186/s12879-023-08210-2.
3
Prevalence and genotype specific concordance of oro-genital and anal human papillomavirus infections among sexually active Nigerian women.性活跃的尼日利亚女性中口腔生殖器和肛门人乳头瘤病毒感染的患病率及基因型特异性一致性
Infect Agent Cancer. 2021 Sep 8;16(1):59. doi: 10.1186/s13027-021-00398-9.
4
Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.喀麦隆林贝地区感染艾滋病毒女性和未感染艾滋病毒女性的宫颈人乳头瘤病毒DNA检测
J Clin Virol. 2020 Jul;128:104445. doi: 10.1016/j.jcv.2020.104445. Epub 2020 May 19.
5
The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study.坦桑尼亚艾滋病毒预防和控制对 HPV 和宫颈癌的过去、现在和未来影响:建模研究。
PLoS One. 2020 May 6;15(5):e0231388. doi: 10.1371/journal.pone.0231388. eCollection 2020.
6
Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.在SurePath保存液中,比较Cepheid Xpert人乳头瘤病毒检测法与HC2高危型人乳头瘤病毒DNA检测法对宫颈涂片样本中高危型人乳头瘤病毒感染的检测情况。
J Med Microbiol. 2018 May;67(5):676-680. doi: 10.1099/jmm.0.000723.

本文引用的文献

1
Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.Xpert人乳头瘤病毒检测对于HIV血清反应阳性女性而言是一种很有前景的宫颈癌筛查检测方法。
Papillomavirus Res. 2016 Dec;2:56-60. doi: 10.1016/j.pvr.2016.02.004. Epub 2016 Mar 3.
2
Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.南非约翰内斯堡感染艾滋病毒女性的肛门人乳头瘤病毒(HPV)感染率及肛门发育异常情况
J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):e59-e64. doi: 10.1097/QAI.0000000000001300.
3
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).基于试剂盒的检测临床重要人乳头瘤病毒(HPV)感染方法的性能:来自VALGENT(HPV基因分型检测验证)的经验教训
J Clin Microbiol. 2016 Sep;54(9):2337-42. doi: 10.1128/JCM.00897-16. Epub 2016 Jul 6.
4
Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia.赞比亚HIV感染女性中4种即时护理宫颈癌筛查检测的临床性能验证
J Low Genit Tract Dis. 2016 Jul;20(3):218-23. doi: 10.1097/LGT.0000000000000206.
5
Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.法国组合型抗反转录病毒疗法时代感染人类免疫缺陷病毒的女性肛门致癌型人乳头瘤病毒感染的流行率和危险因素。
J Infect Dis. 2016 May 1;213(9):1455-61. doi: 10.1093/infdis/jiv751. Epub 2015 Dec 21.
6
Screening to prevent anal cancer: Current thinking and future directions.预防肛门癌的筛查:当前的思考与未来方向。
Cancer Cytopathol. 2015 Sep;123(9):509-10. doi: 10.1002/cncy.21571. Epub 2015 Aug 3.
7
Screening for Anal Cancer in Women.女性肛门癌筛查
J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117.
8
Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.女性肛门人乳头瘤病毒感染及肛门HPV相关疾病的患病率:一项系统评价
Am J Obstet Gynecol. 2015 Sep;213(3):278-309. doi: 10.1016/j.ajog.2015.03.034. Epub 2015 Mar 19.
9
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population.Xpert HPV检测法在阴道镜转诊人群中检测高危型人乳头瘤病毒DNA的可靠性
Am J Clin Pathol. 2015 Jan;143(1):126-33. doi: 10.1309/AJCP4Q0NSDHWIZGU.
10
HPV in genital cancers (at the exception of cervical cancer) and anal cancers.人乳头瘤病毒与生殖器癌(宫颈癌除外)及肛门癌。
Presse Med. 2014 Dec;43(12 Pt 2):e423-8. doi: 10.1016/j.lpm.2014.10.001. Epub 2014 Oct 30.